1-4 of 4
Alexander Joseph Ambinder
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Comparison of Acute Myeloid Leukemia (AML) Regimens: Hypomethylating Agents Combined with Ivosidenib or Venetoclax in Newly Diagnosed Patients with IDH1 Mutations: A Real-World Evidence Study

B. Douglas Smith, Curtis A Lachowiez, Alexander Joseph Ambinder, Gary Binder, Anne Angiolillo, Assaf Vestin, Robert Paglia, Ravi Potluri, Eros Papademetriou, Thomas W LeBlanc
Journal: Blood
Blood (2023) 142 (Supplement 1): 971.
https://doi.org/10.1182/blood-2023-173033
Published: 2023
Journal Articles

Favorable Outcomes for High-Risk MDS and Oligoblastic AML with MDS-Related Changes with Reduced Intensity Allogeneic Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide

Ilias Sinanidis, Michael Jamie Hochman, Hua-Ling Tsai, Michael P Randall, Brandon Bonilla, Ravi Varadhan, Alexander Joseph Ambinder, Amy E. DeZern, Theodoros Karantanos
Journal: Blood
Blood (2023) 142 (Supplement 1): 3229.
https://doi.org/10.1182/blood-2023-187247
Published: 2023
Journal Articles

Iadademstat and Gilteritinib for the Treatment of FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia: The Frida Study

Amir T. Fathi, Theodore P Braun, Alexander Joseph Ambinder, Gautam Borthakur, Robert L. Redner, Mabel Arevalo, Sonia Gutierrez, Ana Limon, Douglas V. Faller
Journal: Blood
Blood (2023) 142 (Supplement 1): 5974.
https://doi.org/10.1182/blood-2023-189291
Published: 2023
Journal Articles

Transplant Outcomes for IDH-Mutated AML: Good Outcomes Thanks to Keeping Good Company

Alexander Joseph Ambinder, MDMPH, Matthew L Smith, Ravi Varadhan, PhD, Amy E. DeZern, MD, Mark Levis, MD PhD, Gabriel Ghiaur, MD PhD, Richard J. Jones, MD, B. Douglas Smith, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 31–32.
https://doi.org/10.1182/blood-2020-141493
Published: 2020